NNNN
Anbio Biotechnology
6.20$
+1.1%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 94.4% | 18.9% | 13.4% | 25.4% | -77.9% | |
| 0.0% | 0.0% | 0.2% | 0.0% | – | |
| 37.2% | -23.5% | -17.9% | 0.5% | -152.8% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | -6.5% | 25.8% | 4.1% | -48.6% | |
| – | 0.0% | -0.6% | -4.2% | 80.3% | |
| 94.4% | 12.4% | 38.5% | 25.3% | -46.2% | |
| 94.4% | 18.9% | 13.4% | 25.4% | -77.9% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.